TITLE

Medical mist making with a gentle touch

PUB. DATE
April 2004
SOURCE
Engineer (00137758);4/30/2004, Vol. 293 Issue 7650, p6
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
13048609

 

Related Articles

  • Pulmonary Route As An Important Means of Drug Delivery: Inhalers Provided To Meet Our Needs. Shivanand, Pandey; Vasanti, Choudhary; Mahalaxmi, R.; Viral, Devmurari; Jivani, N. P. // Journal of Pharmacy Research;Aug2009, Vol. 2 Issue 8, p1232 

    Inhalers are designed to disperse fine, respirable powders in a reproducible fashion for optimal systemic or local lung delivery. Together with our particle technologies, they create an integrated pulmonary delivery system. We also offer expertise in systems integration of pulmonary therapeutics...

  • Achieving Optimal Particle Size Distribution in Inhalation Therapy. Bruno, Bob // Medical Design Technology;Apr2007, Vol. 11 Issue 4, pS6 

    The article deals with the concerns of medical device manufacturers and their pharmaceutical partners over their attempt to achieve the correct size for an inhalation device in the U.S. One of the challenges faced by manufacturers regarding the making of inhalation therapy is the effect of size...

  • Combination inhalers can cut lung function decline. Liddle, Rachel // GP: General Practitioner;5/25/2007, p2 

    The article reports on the therapeutic benefits of a salmeterol/fluticasone propionate inhalers in treating chronic obstructive pulmonary disease. According to U.S. researchers that it can significantly reduce lung function decline. The study entitled "Towards a revolution in COPD health"...

  • CFC-FREE INHALERS. Haggerty, Sharon // Practice Nurse;4/9/2004, Vol. 27 Issue 7, p48 

    Examines the transition of chlorofluorocarbon (CFC) inhalers to CFC-free versions. Results of a survey on the awareness of respiratory patients at Sunderland Royal Hospital on the CFC issue; Advantages of medication transition; Models for transition of existing patients.

  • Inhalation devices and propellants.  // CMAJ: Canadian Medical Association Journal;11/30/99 Supplement, Vol. 161, pS44 

    The article focuses on the recommendations for the use of inhalation devices and propellants for asthma in children and adults. The article offers guidelines for the use of inhalation devices including pressurized metered-dose inhalers, metered-dose inhalers with spacers, dry-powder inhalers and...

  • BREATHE RIGHT VAPOR SHOT! Haar, Kristina // Joe Weider's Muscle & Fitness;Nov2003, Vol. 64 Issue 11, p38 

    Provides information on the Breathe Right Vapor Shot! personal vaporizer. Advantages over other sinusitis or allergy solutions; Cost.

  • Respira Therapeutics Announces Results of Proof-of-Concept Study in Humans.  // Biomedical Market Newsletter;6/30/2011, p671 

    The article reports on the results announced by Respira Therapeutics Inc. regarding a clinical feasibility study of its drug engine technology (DET) called dry powder inhaler (DPI) for the treatment of asthma and chronic obstructive pulmonary disease (COPD). It notes that the patented DPI drug...

  • Knowledge Limited for Accurately Measuring Contents of Metered Dose Inhalers. Spellman, Marguerite // Pulmonary Reviews;Aug2008, Vol. 13 Issue 8, p19 

    The article discusses research being done on the measurement of the contents of a metered dose inhaler (MDI). It references a study presented at the American Thoracic Society's 104th International Conference. Researchers found that neither providers nor patients have knowledge in determining the...

  • The Future of Metered-Dose Inhalers. Pritchard, John // Pharmaceutical Technology Europe;Sep2005, Vol. 17 Issue 9, p22 

    Advances in pressurized metered-dose inhalers (pMDIs) in terms of formulation capability and the performance of the container closure system enable products to be developed faster and with less technical risk. Despite new delivery devices for new molecules breaking into the pMDI market, pMDIs...

Share

Other Topics